Curis (FRA:CUS0) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 24, 2026)


FRA:CUS0 Curis Inc FRA:CUS0
49 GF Score
Price €0.37
GF Value €1.07
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Curis Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Curis's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

FRA:CUS0 vs HOWL, TRAW, CVM: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Curis's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curis Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curis's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Curis's Margin of Safety % (DCF Earnings Based) falls into.


FRA:CUS0
49GF Score
Curis Inc FRA:CUS0
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Curis (FRA:CUS0) Overvalued in 2026?

Based on GuruFocus' analysis, Curis stock appears to be undervalued. The current stock price of €0.37 is trading 65.2% below its estimated GF Value™ of €1.07. GuruFocus considers Curis to be Possible Value Trap.

Key valuation signals for FRA:CUS0:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: €1.07 vs. price of €0.37 (65.2% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the FRA:CUS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curis Business Description

Other Exchanges CRIS:USA
Address 128 Spring Street, Building C - Suite 500, Lexington, MA, USA, 02421
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
49GF Score

Get the complete analysis for FRA:CUS0

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€1.07
GF Value